Anthony Infante, DO
Orthopaedic Surgery · Sun City Center, FLNPI 1720083454
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $52,403 of the $63,324 with a category attached, or 82.8%. Omnilife Science, Inc accounts for 83.3% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2020 at $29,708 and has fallen 95.1% since, to $1,462 in 2025.
Across 159 payments — averaging $398.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Omnilife Science, Inc$53K
- Davol Inc.$2K
- MVP Orthopedics Inc$2K
- Zimmer Biomet$1K
- Globus Medical$841
- Smith+Nephew$738
- plus $4K from 32 others
What the payments were for
- Royalty or licence$52,40383%
- Speaking & faculty fees$2,0003%
- Food & beverage$6,95111%
- Education$1,9713%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Omnilife Science, Inc | 13 | $52,757 |
| Davol Inc. | 2 | $2,082 |
| MVP Orthopedics Inc | 1 | $1,971 |
| Zimmer Biomet | 20 | $1,097 |
| Globus Medical | 2 | $841 |
| Smith+Nephew | 29 | $738 |
| Stryker(2 entities) | 17 | $737 |
| Coastal Medical Technologies LLC | 15 | $367 |
| Paragon 28, Inc. | 2 | $290 |
| Bioventus LLC | 12 | $209 |
| ERMI LLC | 4 | $169 |
| Osteocentric Technologies, Inc. | 1 | $159 |
| Innovation Technologies Inc | 1 | $156 |
| Sanara Medtech Inc. | 2 | $152 |
| Johnson & Johnson | 1 | $141 |
| Pacira Therapeutics, Inc. | 6 | $128 |
| Onkos Surgical, Inc. | 1 | $128 |
| Biocomposites Inc | 1 | $121 |
| Acumed LLC | 1 | $120 |
| Arthrex | 1 | $119 |
| Novo Nordisk | 1 | $115 |
| Amgen | 2 | $110 |
| Acell, Inc. | 1 | $102 |
| Integra Lifesciences Corporation | 4 | $93 |
| Maxx Orthopedics, Inc. | 2 | $66 |
| Next Science LLC | 2 | $61 |
| Ortho Development Corporation | 1 | $51 |
| Illuminoss Medical, Inc. | 1 | $35 |
| Abbott | 2 | $30 |
| Maxx Health Inc | 1 | $28 |
| Heraeus Medical, LLC. | 3 | $26 |
| Baxter Healthcare | 1 | $25 |
| Edwards Lifesciences | 1 | $21 |
| KCI USA, Inc. | 1 | $19 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Molnlycke Health Care US, LLC | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Autobahn$811
- Persona$233
- REAL INTELLIGENCE$160
- Unifi Technology$159
- Irrisept$156
- TRAUMA$150
- TFN-Advance$141
- TRAUMA PORTFOLIO$140
- mymobility Platform$126
- Stimulan$121
- Hand Fracture System$120
- Cannulated Screw System$120
- Arc Wrist Tower$120
- Comp Reverse Humeral Tray$119
- DISTAL EXTREMITIES IMPLANTS EXTREMITY FRACTURE MANAGEMENT ANKLE FRACTURE$119
- G7$118
- Wegovy$115
- CellerateRx$106
- MAKO$106
How this compares
$63,324 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 181 | $2,375 |
| Meloxicam | 387 | $1,283 |
| Celecoxib | 64 | $1,058 |
| Cephalexin | 117 | $790 |
| Mupirocin | 120 | $735 |
| Tramadol Hcl | 190 | $586 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 63 | $475 |
| Doxycycline Hyclate | 12 | $375 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 52 | $324 |
| Oxycodone Hcl | 64 | $323 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $217 |
| Clindamycin Hcl | 16 | $86 |
| Gabapentin | 18 | $75 |
| Levofloxacin | 22 | $68 |
| Amoxicillin | 47 | $66 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Sun City Center
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.